5-Minute Emergency Consult
Seborrheic Dermatitis
Seborrheic Dermatitis is a topic covered in the 5-Minute Emergency Consult.
To view the entire topic, please log in or purchase a subscription.
Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:
-- The first section of this topic is shown below --
Basics
Description
Description
- A common and chronic papulosquamous inflammatory skin disorder
- Affects all age groups and varies from mild dandruff to extensive adherent scale
- Found in areas with high concentrations of sebaceous follicles and glands
- Sharply demarcated yellow to red to brown, greasy, scaling, crusting patches/plaques
- Periods of remission and exacerbation frequent in adults
Etiology
Etiology
- Exact pathogenesis not fully understood
- Multifactorial with environmental, genetic, hormonal, immunologic, microbial, and nutritional influences
- Strong association with Malassezia yeasts
- Complex physiologic response:
- Immunologic
- Inflammatory
- Hyperproliferation
- Disease flares are common with physical and emotional stress or illness
- Factors predisposing patients to develop seborrheic dermatitis and more severe or refractory disease:
- Parkinson disease
- Paralysis
- HIV/AIDS
- Mood disorders including depression
- Congestive heart failure
- Immunosuppression in premature infants
- Medications known to induce or aggravate seborrheic dermatitis include:
- Arsenic
- Auranofin
- Aurothioglucose
- Buspirone
- Carbamazepine
- Chlorpromazine
- Cimetidine
- Ethionamide
- Gold
- Griseofulvin
- Haloperidol
- Interferon-α
- Lithium
- Methoxsalen
- Methyldopa
- Phenothiazines
- Phenytoin
- Primidone
- Psoralen
- Stanozolol
- Thiothixene
- Trioxsalen
-- To view the remaining sections of this topic, please log in or purchase a subscription --
Basics
Description
Description
- A common and chronic papulosquamous inflammatory skin disorder
- Affects all age groups and varies from mild dandruff to extensive adherent scale
- Found in areas with high concentrations of sebaceous follicles and glands
- Sharply demarcated yellow to red to brown, greasy, scaling, crusting patches/plaques
- Periods of remission and exacerbation frequent in adults
Etiology
Etiology
- Exact pathogenesis not fully understood
- Multifactorial with environmental, genetic, hormonal, immunologic, microbial, and nutritional influences
- Strong association with Malassezia yeasts
- Complex physiologic response:
- Immunologic
- Inflammatory
- Hyperproliferation
- Disease flares are common with physical and emotional stress or illness
- Factors predisposing patients to develop seborrheic dermatitis and more severe or refractory disease:
- Parkinson disease
- Paralysis
- HIV/AIDS
- Mood disorders including depression
- Congestive heart failure
- Immunosuppression in premature infants
- Medications known to induce or aggravate seborrheic dermatitis include:
- Arsenic
- Auranofin
- Aurothioglucose
- Buspirone
- Carbamazepine
- Chlorpromazine
- Cimetidine
- Ethionamide
- Gold
- Griseofulvin
- Haloperidol
- Interferon-α
- Lithium
- Methoxsalen
- Methyldopa
- Phenothiazines
- Phenytoin
- Primidone
- Psoralen
- Stanozolol
- Thiothixene
- Trioxsalen
There's more to see -- the rest of this entry is available only to subscribers.
Citation
Schaider, Jeffrey J., et al., editors. "Seborrheic Dermatitis." 5-Minute Emergency Consult, 5th ed., Lippincott Williams & Wilkins, 2016. Emergency Central, emergency.unboundmedicine.com/emergency/view/5-Minute_Emergency_Consult/307189/1.3/Seborrheic_Dermatitis.
Seborrheic Dermatitis. In: Schaider JJJ, Barkin RMR, Hayden SRS, et al, eds. 5-Minute Emergency Consult. Lippincott Williams & Wilkins; 2016. https://emergency.unboundmedicine.com/emergency/view/5-Minute_Emergency_Consult/307189/1.3/Seborrheic_Dermatitis. Accessed September 18, 2021.
Seborrheic Dermatitis. (2016). In Schaider, J. J., Barkin, R. M., Hayden, S. R., Wolfe, R. E., Barkin, A. Z., Shayne, P., & Rosen, P. (Eds.), 5-Minute Emergency Consult (5th edition). Lippincott Williams & Wilkins. https://emergency.unboundmedicine.com/emergency/view/5-Minute_Emergency_Consult/307189/1.3/Seborrheic_Dermatitis
Seborrheic Dermatitis [Internet]. In: Schaider JJJ, Barkin RMR, Hayden SRS, Wolfe RER, Barkin AZA, Shayne PP, Rosen PP, editors. 5-Minute Emergency Consult. Lippincott Williams & Wilkins; 2016. [cited 2021 September 18]. Available from: https://emergency.unboundmedicine.com/emergency/view/5-Minute_Emergency_Consult/307189/1.3/Seborrheic_Dermatitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Seborrheic Dermatitis
ID - 307189
ED - Barkin,Adam Z,
ED - Shayne,Philip,
ED - Rosen,Peter,
ED - Schaider,Jeffrey J,
ED - Barkin,Roger M,
ED - Hayden,Stephen R,
ED - Wolfe,Richard E,
BT - 5-Minute Emergency Consult
UR - https://emergency.unboundmedicine.com/emergency/view/5-Minute_Emergency_Consult/307189/1.3/Seborrheic_Dermatitis
PB - Lippincott Williams & Wilkins
ET - 5
DB - Emergency Central
DP - Unbound Medicine
ER -
